These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28846151)

  • 1. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience.
    Ruzieh M; Sirianni N; Ammari Z; Dasa O; Alhazmi L; Karabin B; Grubb B
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1242-1245. PubMed ID: 28846151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
    Gee ME; Watkins AK; Brown JN; Young EJA
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):195-204. PubMed ID: 29330767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children.
    Delle Donne G; Rosés Noguer F; Till J; Salukhe T; Prasad SK; Daubeney PEF
    Am J Cardiovasc Drugs; 2018 Feb; 18(1):59-63. PubMed ID: 29027608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
    Taub PR; Zadourian A; Lo HC; Ormiston CK; Golshan S; Hsu JC
    J Am Coll Cardiol; 2021 Feb; 77(7):861-871. PubMed ID: 33602468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome.
    McDonald C; Frith J; Newton JL
    Europace; 2011 Mar; 13(3):427-30. PubMed ID: 21062792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study.
    Towheed A; Nesheiwat Z; Mangi MA; Karabin B; Grubb BP
    Cardiol Young; 2020 Jul; 30(7):975-979. PubMed ID: 32498748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for postural tachycardia syndrome.
    Miller AJ; Raj SR
    Auton Neurosci; 2018 Dec; 215():28-36. PubMed ID: 29753556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
    Tahir F; Bin Arif T; Majid Z; Ahmed J; Khalid M
    Cureus; 2020 Apr; 12(4):e7868. PubMed ID: 32489723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience.
    Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postural orthostatic tachycardia syndrome (POTS): report of 15 cases].
    Jiménez-Cohl P; Earle NM; González BR; Thieck EJ
    Rev Med Chil; 2012 Feb; 140(2):145-52. PubMed ID: 22739942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.
    Mathew ST; Po SS; Thadani U
    Heart Rhythm; 2018 Feb; 15(2):240-247. PubMed ID: 29017929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome.
    Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Sheikh M; Grubb BP
    Am J Ther; 2012 Mar; 19(2):92-5. PubMed ID: 20838326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope.
    Sutton R; Salukhe TV; Franzen-McManus AC; Collins A; Lim PB; Francis DP
    Europace; 2014 Feb; 16(2):284-8. PubMed ID: 24072450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study.
    Abdelnabi M; Saleh Y; Ahmed A; Benjanuwattra J; Leelaviwat N; Almaghraby A
    Am J Cardiovasc Dis; 2023; 13(3):162-167. PubMed ID: 37469536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
    Barzilai M; Jacob G
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
    Mar PL; Raj SR
    Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droxidopa in the Treatment of Postural Orthostatic Tachycardia Syndrome.
    Ruzieh M; Dasa O; Pacenta A; Karabin B; Grubb B
    Am J Ther; 2017; 24(2):e157-e161. PubMed ID: 27563801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural Tachycardia Syndrome and COVID-19: Focus on Ivabradine Therapy.
    Dixit K; Frishman WH
    Cardiol Rev; 2024 May-Jun 01; 32(3):279-284. PubMed ID: 36729924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postural orthostatic tachycardia syndrome (POTS).
    Sidhu B; Obiechina N; Rattu N; Mitra S
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24042210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.